Pienomial

What Pienomial does

Pienomial is a Rockville, Maryland-based enterprise AI company founded in 2020 that has built Knolens, a knowledge graph-based Enterprise Context Graph platform designed for regulated industries including life sciences, financial services, consulting, and public sector organizations. The platform's core architecture uses a persistent knowledge layer that structures information as entities, relationships, and context rather than relying on vector databases or RAG approaches, enabling what the company claims is zero-hallucination AI with full source traceability. The product suite is organized as a platform-plus-modules architecture: KnolForge serves as the foundational knowledge layer, with KnolAI (research and discovery), KnolComposer (evidence-based document authoring), KnolPersona (expert intelligence and validation), and KnolModels (explainable predictive modeling, coming soon) built on top. The platform supports deployment within customer environments including private cloud, on-premise, or air-gapped configurations, with LLM-agnostic integration supporting GPT-4, Claude, Mistral, and other models.

The company operates a sales-led enterprise go-to-market targeting large pharmaceutical companies, financial institutions, consulting firms, and government agencies. Revenue is generated through enterprise software subscriptions, though specific pricing is not publicly disclosed. Customer engagement begins with demo requests rather than self-service signup, consistent with complex, compliance-focused deployments. The company claims measurable outcomes including 3x acceleration of regulatory submissions, 75% reduction in evidence analysis costs, 90% reduction in product failure, and $50M saved through reduced product recalls. Pienomial has secured one disclosed funding round from Neon Fund (amount undisclosed) in 2023, holds 7 patented innovations, and operates with a team of 11-50 employees. The company is led by CEO Sanat Mohanty and remains privately held.

Name

Pienomial

Legal name

Pienomial

Website

https://pienomial.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Pienomial is a Rockville, MD-based enterprise AI company that builds Knolens, a knowledge graph-based AI memory platform for regulated industries. It serves pharmaceutical, financial services, consulting, and government organizations requiring traceable, audit-ready AI deployed within their own environments.

Ownership category

akta.pro rank

Product category

Enterprise AI Platform

NAICS

Software Publishers (5132)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ)

akta.pro secondary industry

Responsible AI, Security & Privacy Platforms (Safety, Guardrails, PII) (HDAEANAG)

Keywords

• Enterprise AI platform
• Knowledge graph AI
• Regulatory compliance AI
• Enterprise intelligence software
• AI memory layer

Headquarters

HQ city

Rockville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Enterprise Software Platform Subscription: Knolens platform and its product modules (KnolForge, KnolAI, KnolComposer, KnolPersona, KnolModels) are sold as enterprise software subscriptions. The platform is deployed within customer environment (private cloud, on-premise, or air-gapped), suggesting a platform licensing model with enterprise contracts.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Pienomial sells the Knolens enterprise Knowledge and AI Memory Platform, a knowledge graph-native AI software platform deployed inside customer environments (private cloud, on-premise, or air-gapped). The platform is sold as a core foundation (KnolForge) plus integrated modules for traceable AI research (KnolAI), evidence-based document authoring (KnolComposer), expert intelligence simulation (KnolPersona), and explainable predictive modeling (KnolModels), with vertical intelligence lenses for clinical trials (Trial Lens) and competitive intelligence (CI Lens).

Product overview

Pienomial offers Knolens, an enterprise-grade Knowledge & AI Memory Platform with a unified platform-plus-modules architecture. The core platform is KnolForge, which serves as the foundational knowledge layer powering all products. Built on top of KnolForge are four integrated products: KnolAI (research and discovery), KnolComposer (evidence-based document authoring), KnolPersona (expert intelligence and validation), and KnolModels (explainable predictive modeling - coming soon). All products operate on a shared knowledge foundation, ensuring consistency, traceability, and intelligence reuse across use cases. The platform is LLM-agnostic, privately deployed, and designed for regulated industries requiring zero hallucination and full audit trails.

Differentiator

Problem solved

Functional benefit

Brands

• Knolens: Enterprise Knowledge & AI Memory Platform - a trusted AI platform for organizations where being wrong has consequences
• KnolComposer
• KnolPersona
• KnolAI
• KnolForge
• KnolModels
• Trial Lens
• CI Lens

Products and services

• KnolForge Foundational Enterprise Knowledge and AI Memory Platform where organizations deploy, manage, and build on Pienomial's knowledge graph-native platform. Serves as the operating system for enterprise intelligence, transforming raw data into governed knowledge graphs and connecting any LLM or specialized model to the knowledge layer.
• KnolAI Enterprise AI research and discovery tool for deep scientific and domain research with full source control, verification, and audit trails. Enables deep, traceable research across structured and unstructured sources with inline citations tied directly to source documents.
• KnolComposer Domain-centric content and document authoring platform for regulated, research-driven enterprises. Transforms research into structured, living documents for regulatory, analytical, and strategic use with built-in traceability, continuous updates, and evidence-backed authoring workflows.
• KnolPersona Enterprise AI expert intelligence system that enables structured, traceable interactions with domain experts across medical, clinical, regulatory, and functional specialties. Simulates domain experts to validate insights, review outputs, and support decision-making with explainable, knowledge-backed reasoning.
• KnolModels Explainable modeling product supporting advanced analytical and predictive modeling, enabling scenario analysis, forecasting, and explainable decision intelligence. Supports clinical, scientific, and economic modeling with transparent assumptions, reusable logic, and fully explainable outputs. Status listed as Coming Soon.
• Trial Lens Clinical Trial Intelligence lens built on the Knolens platform, providing an intelligence layer for clinical trial planning, evaluation, and decision-making built on traceable evidence.
• CI Lens Competitive Intelligence Lens built on the Knolens platform, providing an intelligence layer for strategic planning, market access, and portfolio decisions built on traceable evidence.

Quantifiable outcome

• Accelerated regulatory submissions by 3x
• +5 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature8 records

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Writer: Enterprise AI platform with an LLM-agnostic, privately deployed architecture and a focus on traceable outputs for regulated industries — closely comparable to Pienomial's sovereign, audit-ready AI positioning.
• Glean: Enterprise AI search and knowledge layer that connects to internal data sources to deliver grounded answers with citations — a direct functional analog to KnolAI/KnolForge, with comparable enterprise GTM and traceability messaging.
• AlphaSense: Market intelligence and enterprise search platform heavily used by life-sciences strategy, CI, and consulting teams — overlaps directly with Pienomial's Trial Lens and CI Lens use cases in pharma evidence synthesis and competitive intelligence.
• Neo4j: Leading graph database underpinning many enterprise knowledge-graph applications; Pienomial's Enterprise Context Graph competes architecturally with Neo4j-based stacks in regulated industries where graph reasoning and traceability are required.
• TigerGraph: Graph database and analytics platform used for enterprise knowledge graphs; a comparable infrastructure-layer alternative for regulated enterprises building AI on top of structured entity-relationship data.

Broad incumbents

• C3.ai: Enterprise AI application platform selling pre-built, governable AI solutions into regulated industries (financial services, defense, energy) — broader scope than Pienomial but similar enterprise-grade, auditable AI value proposition.
• IQVIA: Largest life-sciences commercial and clinical intelligence provider — competes directly with Pienomial's Life Sciences and Trial Lens offerings in market access, HEOR, and clinical trial decision support, with vastly greater domain data assets.
• Palantir Technologies: Enterprise data/AI platform (Foundry, AIP) with strong presence in pharma, finance, and government that emphasizes ontology-based knowledge modeling and on-premise/air-gapped deployment — directly comparable to Pienomial's regulated-vertical and sovereign-AI positioning, but at vastly greater scale and breadth.
• Cohere: Enterprise LLM provider with private deployment, retrieval, and agent frameworks; competes for the same 'enterprise-grade AI with data sovereignty' budget and is one of the model options Pienomial explicitly supports.

Emerging players

• Hebbia: Enterprise AI analyst platform purpose-built for finance, legal, and consulting workflows that ingests large document corpora and produces cited answers — directly comparable to KnolAI/KnolComposer for research-driven enterprises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pienomial